Nothing said here yet.
to join the conversation.
| Catapano Joseph RonaldChief Accounting Officer | Sell | 655 | $3.7K | Fri, Oct 2 |
| DIVITA CHARLES IIICHIEF EXECUTIVE OFFICER | Sell | 17,805 | $108.7K | Fri, Sep 11 |
| Rodrigues Fernando M.President of BetterHelp | Sell | 9,812 | $63.9K | Thu, Sep 3 |
| DIVITA CHARLES IIICHIEF EXECUTIVE OFFICER | Sell | 18,327 | $115.5K | Wed, Sep 2 |
| Vandervoort Adam CCHIEF LEGAL OFFICER, SECRETARY | Sell | 7,573 | $47.7K | Wed, Sep 2 |
| Bliss KellyPresident, U.S. Group Health | Sell | 7,357 | $46.4K | Wed, Sep 2 |
| Nueno CarlosPresident, International | Sell | 6,200 | $39.1K | Wed, Sep 2 |
| Rodrigues Fernando M.President of BetterHelp | Sell | 5,439 | $34.3K | Wed, Sep 2 |
| Catapano Joseph RonaldChief Accounting Officer | Sell | 274 | $1.7K | Wed, Sep 2 |
Teladoc’s third-quarter results were met with a significant positive market reaction, reflecting investor confidence in the company’s execution despite a year-over-year revenue decline.
Teladoc Health just ripped higher, jumping 26.9% to US$8.73 after its Q3 2026 report, a sharp rerating for a stock that had been under pressure for months.
Key TakeawaysTeladoc Health rose 11% after its third-quarter adjusted EBITDA beat guidance, rising 14% to $79. 4 million.
Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 24.2% in the morning session after the company reported third-quarter financial results that exceeded its adjusted EBITDA guidance and reached near the upper end of its revenue…
Moby summary of Teladoc Health, Inc.'s Q3 2026 earnings call
Teladoc Health (NYSE:TDOC) reported third-quarter 2026 revenue near the upper end of its guidance range and adjusted EBITDA above expectations, as growth in Integrated Care and BetterHelp insurance revenue partly offset continued pressure in BetterHelp’s…
A unified care platform and insurance-focused strategy position Teladoc to stabilize revenue while managing $1 billion in convertible debt due next June.
Insurance mental health revenue surged amid cash-pay headwinds.
The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Teladoc (TDOC) delivered earnings and revenue surprises of +34.78% and +3.34%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?